Evolus, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
EOLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
520 Newport Center Drive, Suite 1200, Newport Beach, CA

Insiders trading volume in the past year

Evolus, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alphaeon 1 LLC 10%+ Owner $35.4M Feb 17, 2023
Medytox Inc. Former 10% Owner $25.4M Oct 16, 2023
David Moatazedi CEO and President, Director $8.49M -$8.56M -50.2% Jun 4, 2024
Simone Blank Director $7.26M Feb 7, 2024
Rui Avelar Chief Medical Officer & Head of Research and Development $4.92M -$452K -8.41% May 10, 2024
Vikram Malik Director $3.19M -$459K -12.6% Jun 3, 2024
Sandra Beaver Chief Financial Officer $2.46M -$183K -6.92% Sep 6, 2024
Tomoko Yamagishi-Dressler Chief Marketing Officer $1.47M -$89.3K -5.73% Aug 30, 2024
Lauren P. Silvernail Chief Financial Officer and Executive Vice President, Corporate Development $1.38M May 17, 2022
Crystal Muilenburg Chief Marketing Officer $1.31M Mar 8, 2022
Robert Hayman Director $857K Feb 7, 2024
Brady Stewart Director $673K Feb 7, 2024
Peter C. Farrell Director $517K Jan 27, 2023
Karah Herdman Parschauer Director $495K -$157K -24% Feb 7, 2024
David N. Gill Director $428K -$131K -23.4% May 13, 2024
Albert G. White III Director $290K Jul 1, 2024

Recent Insider Transactions by Companies or Individuals for Evolus, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.